Buscar resultados de ensayos clínicos
Leishmaniasis - 87 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2012-03-27 Intervenciones: Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
Terminated |
Nombre del estudio: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil Condición: Visceral Leishmaniasis Fecha: 2011-03-07 Intervenciones:
|
Terminated |
Nombre del estudio: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis Condición: Cutaneous Leishmaniasis Fecha: 2008-05-20 Intervenciones:
|
Completed |
Nombre del estudio: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia Condición: Cutaneous Leishmaniasis Fecha: 2005-09-28 Intervenciones:
|
Recruiting |
Nombre del estudio: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry Condición: Leishmaniasis Fecha: 2015-04-22 Intervenciones: Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days |
Completed |
Nombre del estudio: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol Condición: Leishmaniasis, Cutaneous Fecha: 2007-05-29 Intervenciones:
|
Available |
Nombre del estudio: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2012-06-18 Intervenciones: Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
Completed |
Nombre del estudio: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2005-05-23 Intervenciones: Biological: Leish-111f + MPL-SE vaccine |
Terminated |
Nombre del estudio: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Condición: Leishmaniasis, Cutaneous Fecha: 2010-06-07 Intervenciones: Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
Completed |
Nombre del estudio: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) Condición: Leishmaniasis, Cutaneous Fecha: 2009-12-14 Intervenciones:
|